Skip to main content

Table 1 GP/GP trainee respondent demographics

From: Low knowledge and awareness of monoclonal gammopathy of undetermined significance (MGUS) among general practitioners

 

Total (n = 58)

Registered GP (n = 35)

GP trainee (n = 23)

p-value*

Gender

 Male

32 (55.2)

22 (62.9)

10 (43.5)

0.15

 Female

26 (44.8)

13 (37.1)

13 (56.5)

 

Continent

 Europe

47 (81)

27 (77.1)

20 (87)

0.54

 The Americas

3 (5.2)

1 (2.9)

2 (8.7)

 Asian

6 (10.3)

5 (14.3)

1 (4.4)

 Africa

1 (1.7)

1 (2.9)

0

 Missing

1 (1.7)

1 (2.9)

0

Years working as a GP or trainee since completing medical degree

 0–5 years

25 (43.1)

5 (14.3)

20 (87)

≤0.001

 6–10 years

13 (22.4)

11 (31.4)

2 (8.7)

 11–20 years

13 (22.4)

13 (37.1)

0

 20+ years

7 (12.1)

6 (17.1)

1 (4.4)

GP Practice

 Metropolitan/urban

42 (72.4)

25 (71.4)

17 (73.9)

0.52

 Rural

15 (25.9)

10 (28.6)

5 (21.7)

 Prefer not to say/Not applicable

1 (1.7)

0

1 (4.4)

Number of patients within GP/Family practice

 0–500 patients

3 (5.2)

1 (2.9)

2 (8.7)

0.83

 501–1000 patients

3 (5.2)

2 (5.7)

1 (4.4)

 1001–2000 patients

25 (43.1)

16 (45.7)

9 (39.1)

 2001+ patients

27 (46.6)

16 (45.7)

11 (47.8)

Number of MGUS patients that have/are currently within GP/Family practice

 None

8 (13.8)

5 (14.3)

3 (13)

0.19

 1–10 patients

24 (41.4)

18 (51.4)

6 (26.1)

 11–50 patients

5 (8.6)

2 (5.7)

3 (13)

 51–100 patients

1 (1.7)

1 (2.9)

0

 Don’t know/Prefer not to say/Not applicable

20 (34.5)

9 (25.7)

11 (47.8)

  1. *Fisher’s exact test used to estimate p-value where cell count < 5